002412 汉森制药
已收盘 04-30 15:00:00
资讯
新帖
简况
汉森制药：公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失
证券之星 · 04-30 15:09
汉森制药：公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失
汉森制药（002412）2026年一季报简析：净利润同比增长241.17%，盈利能力上升
证券之星 · 04-29 08:51
汉森制药（002412）2026年一季报简析：净利润同比增长241.17%，盈利能力上升
异动快报：汉森制药（002412）4月28日9点36分触及涨停板
证券之星 · 04-28
异动快报：汉森制药（002412）4月28日9点36分触及涨停板
图解汉森制药年报：第四季度单季净利润同比增长29.17%
证券之星 · 04-28
图解汉森制药年报：第四季度单季净利润同比增长29.17%
股市必读：汉森制药（002412）4月15日董秘有最新回复
证券之星 · 04-16
股市必读：汉森制药（002412）4月15日董秘有最新回复
股市必读：汉森制药(002412)股东户数3.13万户，较上期增加40.32%
证券之星 · 03-30
股市必读：汉森制药(002412)股东户数3.13万户，较上期增加40.32%
汉森制药：截至2026年2月27日，公司含信用账户合并股东名册的股东总数为
证券之星 · 03-27
汉森制药：截至2026年2月27日，公司含信用账户合并股东名册的股东总数为
股市必读：汉森制药（002412）3月23日收盘跌7.75%，主力净流出712.64万元
证券之星 · 03-24
股市必读：汉森制药（002412）3月23日收盘跌7.75%，主力净流出712.64万元
汉森制药：汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园
证券之星 · 03-06
汉森制药：汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园
汉森制药(002412)2月27日股东户数3.13万户，较上期增加40.32%
证券之星 · 03-04
汉森制药(002412)2月27日股东户数3.13万户，较上期增加40.32%
汉森制药：截至2026年2月27日股东总数为31288人
证券之星 · 03-03
汉森制药：截至2026年2月27日股东总数为31288人
汉森制药(002412)1月30日股东户数2.23万户，较上期减少7.65%
证券之星 · 02-26
汉森制药(002412)1月30日股东户数2.23万户，较上期减少7.65%
汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为
证券之星 · 02-24
汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为
汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为
证券之星 · 02-12
汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为
股市必读：汉森制药2月6日涨停收盘，收盘价7.59元
证券之星 · 02-09
股市必读：汉森制药2月6日涨停收盘，收盘价7.59元
行业重磅政策助力，汉森制药股价涨停
证券之星 · 02-06
行业重磅政策助力，汉森制药股价涨停
异动快报：汉森制药（002412）2月6日9点34分触及涨停板
证券之星 · 02-06
异动快报：汉森制药（002412）2月6日9点34分触及涨停板
股市必读：汉森制药(002412)股东户数2.23万户，较上期减少7.65%
证券之星 · 02-05
股市必读：汉森制药(002412)股东户数2.23万户，较上期减少7.65%
汉森制药：公司的主导产品已全部修订完毕
证券之星 · 02-04
汉森制药：公司的主导产品已全部修订完毕
汉森制药：公司暂无相关药物
证券之星 · 01-30
汉森制药：公司暂无相关药物
加载更多
公司概况
公司名称：
湖南汉森制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-05-25
主营业务：
湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是四磨汤口服液、缩泉胶囊、银杏叶胶囊、愈伤灵胶囊、天麻醒脑胶囊、肠胃宁、利胆止痛胶囊、胃肠灵胶囊、固体口服制剂、液体口服制剂、注射剂。
发行价格：
35.80
{"stockData":{"symbol":"002412","market":"SZ","secType":"STK","nameCN":"汉森制药","latestPrice":6.99,"timestamp":1777532604000,"preClose":7.01,"halted":0,"volume":30428240,"delay":0,"changeRate":-0.0029,"floatShares":498000000,"shares":503000000,"eps":0.4477,"marketStatus":"已收盘","change":-0.02,"latestTime":"04-30 15:00:00","open":6.99,"high":7.11,"low":6.92,"amount":214000000,"amplitude":0.0271,"askPrice":7,"askSize":639,"bidPrice":6.99,"bidSize":577,"shortable":0,"etf":0,"ttmEps":0.4477,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":7.01,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":7.71,"lowLimit":6.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":503200000,"isCdr":false,"pbRate":1.46,"roa":"--","peRate":15.613134,"roe":"1.6%","epsLYR":0.3937,"committee":-0.3271,"marketValue":3517000000,"turnoverRate":0.0611,"status":1,"floatMarketCap":3480000000},"requestUrl":"/m/hq/s/002412","defaultTab":"news","newsList":[{"id":"2631500566","title":"汉森制药：公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失","url":"https://stock-news.laohu8.com/highlight/detail?id=2631500566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631500566?lang=zh_cn&edition=full","pubTime":"2026-04-30 15:09","pubTimestamp":1777532955,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)04月29日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年年报显示，公司应收账款占比较高，但坏账准备占总资产比例只有0.01%，请问公司是否在故意调节坏账准备？汉森制药回复：尊敬的投资者您好，公司严格按照《企业会计准则》等有关规定，采用整个存续期的预期信用损失的金额计量减值损失。不存在故意调节的行为。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000046128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0039","BK0239","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555339","title":"汉森制药（002412）2026年一季报简析：净利润同比增长241.17%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631555339?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:51","pubTimestamp":1777423877,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期汉森制药发布2026年一季报。截至本报告期末，公司营业总收入2.63亿元，同比下降2.25%，归母净利润3840.64万元，同比上升241.17%。本报告期汉森制药盈利能力上升，毛利率同比增幅3.54%，净利率同比增幅249.02%。去年的净利率为19.07%，算上全部成本后，公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900027465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630533347","title":"异动快报：汉森制药（002412）4月28日9点36分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2630533347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630533347?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:40","pubTimestamp":1777340443,"startTime":"0","endTime":"0","summary":"证券之星4月28日盘中消息，9点36分汉森制药（002412）触及涨停板。其所属行业中药目前上涨。领涨股为汉森制药。该股为流感，中药，医药概念热股，当日流感概念上涨1.12%，中药概念上涨0.39%，医药概念上涨0.32%。4月27日的资金流向数据方面，主力资金净流入404.05万元，占总成交额6.72%，游资资金净流入95.05万元，占总成交额1.58%，散户资金净流出499.1万元，占总成交额8.3%。近5日资金流向一览见下表：汉森制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800029846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630199523","title":"图解汉森制药年报：第四季度单季净利润同比增长29.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630199523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630199523?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:25","pubTimestamp":1777310733,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药2025年年报显示，当年度公司主营收入10.39亿元，同比上升3.41%；归母净利润1.98亿元，同比下降10.05%；扣非净利润1.9亿元，同比下降10.08%；其中2025年第四季度，公司单季度主营收入2.98亿元，同比下降4.03%；单季度归母净利润1.16亿元，同比上升29.17%；单季度扣非净利润1.13亿元，同比上升27.77%；负债率11.59%，投资收益634.82万元，财务费用72.32万元，毛利率77.36%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800003945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627115231","title":"股市必读：汉森制药（002412）4月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2627115231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627115231?lang=zh_cn&edition=full","pubTime":"2026-04-16 01:32","pubTimestamp":1776274331,"startTime":"0","endTime":"0","summary":"截至2026年4月15日收盘，汉森制药报收于6.72元，上涨1.82%，换手率3.18%，成交量15.83万手，成交额1.06亿元。董秘最新回复投资者： 请问截止4月10日股东人数是多少？当日关注点来自交易信息汇总：4月15日主力资金净流入519.05万元，显示主力对个股短期关注度提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600002182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623368752","title":"股市必读：汉森制药(002412)股东户数3.13万户，较上期增加40.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623368752","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623368752?lang=zh_cn&edition=full","pubTime":"2026-03-30 05:11","pubTimestamp":1774818671,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，汉森制药报收于6.55元，上涨3.48%，换手率2.05%，成交量10.21万手，成交额6582.24万元。来自股本股东变化：截至2026年2月27日股东户数环比增长40.32%，户均持股数量下降至1.61万股。交易信息汇总资金流向3月27日主力资金净流入291.07万元；游资资金净流出276.83万元；散户资金净流出14.24万元。股本股东变化股东户数变动近日汉森制药披露，截至2026年2月27日公司股东户数为3.13万户，较1月30日增加8991.0户，增幅为40.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000001095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622848722","title":"汉森制药：截至2026年2月27日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2622848722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622848722?lang=zh_cn&edition=full","pubTime":"2026-03-27 15:00","pubTimestamp":1774594845,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)03月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年3月 20日公司的股东总数是多少？谢谢汉森制药回复：尊敬的投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，截至2026年2月27日，公司含信用账户合并股东名册的股东总数为：31288人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700026228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621086702","title":"股市必读：汉森制药（002412）3月23日收盘跌7.75%，主力净流出712.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621086702","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621086702?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:00","pubTimestamp":1774292439,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，汉森制药报收于6.07元，下跌7.75%，换手率2.75%，成交量13.68万手，成交额8555.56万元。交易信息汇总股价提醒3月23日汉森制药收盘报6.07元，跌7.75%，当日成交1368.41万元。根据收盘数据统计，该股已连续3日下跌。前10个交易日资金流向情况：主力资金累计净流出1438.84万元，股价累计下跌12.62%；融资余额累计增加227.9万元，融券余量累计增加3.51万股。资金流向3月23日主力资金净流出712.64万元；游资资金净流入88.06万元；散户资金净流入624.58万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617187680","title":"汉森制药：汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园","url":"https://stock-news.laohu8.com/highlight/detail?id=2617187680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617187680?lang=zh_cn&edition=full","pubTime":"2026-03-06 20:51","pubTimestamp":1772801503,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药03月05日在投资者关系平台上答复投资者关心的问题。关于中药种植及银发经济、康养相关业务方面，汉森健康产业园项目定位为以中药材种植、科研加工为主，集医养、休闲旅游、商业综合配套为一体的现代农业健康产业园，公司力求将该项目打造成中药材种植加工科研、中医药疗养、中医文化养生旅游三大产业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600037778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616533540","title":"汉森制药(002412)2月27日股东户数3.13万户，较上期增加40.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533540","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616533540?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:10","pubTimestamp":1772615431,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2026年2月27日公司股东户数为3.13万户，较1月30日增加8991.0户，增幅为40.32%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至2月27日，中药行业平均股东户数为5.26万户。从股价来看，2026年1月30日至2026年2月27日，汉森制药区间涨幅为10.24%，在此期间股东户数增加8991.0户，增幅为40.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400029754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","002412","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616395569","title":"汉森制药：截至2026年2月27日股东总数为31288人","url":"https://stock-news.laohu8.com/highlight/detail?id=2616395569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616395569?lang=zh_cn&edition=full","pubTime":"2026-03-03 09:16","pubTimestamp":1772500578,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，请问公司到二月底的股东人数，谢谢汉森制药回复：尊敬的投资者您好，截至2026年2月27日，公司含信用账户合并股东名册的股东总数为：31288人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300007670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","002412","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614016206","title":"汉森制药(002412)1月30日股东户数2.23万户，较上期减少7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614016206","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614016206?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:16","pubTimestamp":1772097415,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2026年1月30日公司股东户数为2.23万户，较11月28日减少1848.0户，减幅为7.65%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至1月30日，中药行业平均股东户数为5.25万户。从股价来看，2025年11月28日至2026年1月30日，汉森制药区间跌幅为1.46%，在此期间股东户数减少1848.0户，减幅为7.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613793481","title":"汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2613793481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613793481?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:09","pubTimestamp":1771920583,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新一期公司的股东人数是多少？汉森制药回复：尊敬的投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，截至2026年1月30日，公司含信用账户合并股东名册的股东总数为：22297人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400028892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002412","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610928749","title":"汉森制药：截至2026年1月30日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2610928749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610928749?lang=zh_cn&edition=full","pubTime":"2026-02-12 11:34","pubTimestamp":1770867266,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止至2026年2月10日收盘公司股东人数为多少，谢谢！汉森制药回复：尊敬的投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，截至2026年1月30日，公司含信用账户合并股东名册的股东总数为：22297人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200014408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0039","002412","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610433572","title":"股市必读：汉森制药2月6日涨停收盘，收盘价7.59元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610433572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610433572?lang=zh_cn&edition=full","pubTime":"2026-02-09 01:08","pubTimestamp":1770570493,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，汉森制药报收于7.59元，上涨10.0%，涨停，换手率15.94%，成交量79.34万手，成交额5.97亿元。交易信息汇总汉森制药2月6日涨停收盘，收盘价7.59元。该股于9点34分涨停，盘中11次打开涨停，截至收盘封单资金为1792.12万元，占其流通市值的0.47%。资金流向2月6日主力资金净流入827.95万元，游资资金净流入266.86万元，散户资金净流出1094.81万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900000564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609537973","title":"行业重磅政策助力，汉森制药股价涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2609537973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609537973?lang=zh_cn&edition=full","pubTime":"2026-02-06 10:24","pubTimestamp":1770344657,"startTime":"0","endTime":"0","summary":"2月6日，中药板块集体大涨。个股方面，汉森制药股价实现涨停。消息面上值得关注的是工业和信息化部等八部门日前联合印发《中药工业高质量发展实施方案》。《方案》明确，到2030年，中药工业全产业链协同发展体系初步形成，重点中药原料持续稳定供应能力进一步增强，数智化、绿色化水平明显提升，一批关键技术取得突破，产业协同创新水平显著提高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026020600011972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609532646","title":"异动快报：汉森制药（002412）2月6日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2609532646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609532646?lang=zh_cn&edition=full","pubTime":"2026-02-06 09:36","pubTimestamp":1770341789,"startTime":"0","endTime":"0","summary":"证券之星2月6日盘中消息，9点34分汉森制药（002412）触及涨停板。其所属行业中药目前上涨。领涨股为达仁堂。该股为中药，流感，医药概念热股，当日中药概念上涨2.01%，流感概念上涨0.87%，医药概念上涨0.71%。2月5日的资金流向数据方面，主力资金净流入87.11万元，占总成交额1.29%，游资资金净流出478.55万元，占总成交额7.07%，散户资金净流入391.44万元，占总成交额5.78%。近5日资金流向一览见下表：汉森制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600009161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0239","BK0028","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609392532","title":"股市必读：汉森制药(002412)股东户数2.23万户，较上期减少7.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609392532","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609392532?lang=zh_cn&edition=full","pubTime":"2026-02-05 02:28","pubTimestamp":1770229692,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，汉森制药报收于6.84元，上涨1.18%，换手率1.39%，成交量6.94万手，成交额4716.86万元。当日关注点来自交易信息汇总：2月4日主力资金净流出179.93万元，散户资金净流入281.2万元。股本股东变化股东户数变动近日汉森制药披露，截至2026年1月30日公司股东户数为2.23万户，较11月28日减少1848.0户，减幅为7.65%。户均持股数量由上期的2.08万股增加至2.26万股，户均持股市值为15.21万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001406.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0039","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608038733","title":"汉森制药：公司的主导产品已全部修订完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2608038733","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608038733?lang=zh_cn&edition=full","pubTime":"2026-02-04 09:06","pubTimestamp":1770167184,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药02月03日在投资者关系平台上答复投资者关心的问题。这意味着，国内现存约5.7万个中成药有效批准文号中，超70%存在安全信息标注问题的批文将面临淘汰。公司的主导产品已全部修订完毕，其他产品已按相关要求在有序推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400007769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","BK0028","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607431063","title":"汉森制药：公司暂无相关药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2607431063","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607431063?lang=zh_cn&edition=full","pubTime":"2026-01-30 08:54","pubTimestamp":1769734450,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)01月29日在投资者关系平台上答复投资者关心的问题。投资者提问：印度东部西孟加拉邦近期出现尼帕病毒的感染病例 ，贵司有专业防范方法和药物吗？汉森制药回复：尊敬的投资者您好，公司暂无相关药物。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000007746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777634936939,"stockEarnings":[{"period":"1week","weight":0.0837},{"period":"1month","weight":0.048},{"period":"3month","weight":0.0371},{"period":"6month","weight":0.0973},{"period":"1year","weight":0.2595},{"period":"ytd","weight":0.0905}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0566},{"period":"3month","weight":-0.0014},{"period":"6month","weight":0.0398},{"period":"1year","weight":0.2541},{"period":"ytd","weight":0.0361}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南汉森制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"27935人(较上一季度减少10.72%)","perCapita":"17821股","listingDate":"2010-05-25","address":"湖南省益阳市赫山区银城大道2688号","registeredCapital":"50320万元","survey":" 湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是四磨汤口服液、缩泉胶囊、银杏叶胶囊、愈伤灵胶囊、天麻醒脑胶囊、肠胃宁、利胆止痛胶囊、胃肠灵胶囊、固体口服制剂、液体口服制剂、注射剂。","listedPrice":35.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汉森制药,002412,汉森制药股票,汉森制药股票老虎,汉森制药股票老虎国际,汉森制药行情,汉森制药股票行情,汉森制药股价,汉森制药股市,汉森制药股票价格,汉森制药股票交易,汉森制药股票购买,汉森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}